Clinical trial · Observational
National Swiss Sarcoma Cohort Study
Prospective Multi-center National Swiss Sarcoma Cohort Study
NCT02775799CI-TRIAL-00035119SwissSARCOSterminatedClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Why stopped (as posted): Principal Investigator has left the Institution
Summary
Brief summary (as posted)
Registration of all sarcoma patients treated at a specialized sarcoma center in Switzerland.
Conditions
Conditions (6)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Neoplasm of Bone | Bone Neoplasm | ALIAS | 0.90 |
| Neoplasms | Neoplasm | ONTOLOGY_EXACT | 0.90 |
| Sarcoma | Sarcoma | ONTOLOGY_EXACT | 0.98 |
| Sarcoma of Bone | Bone Sarcoma | ALIAS | 0.90 |
| Soft Tissue Neoplasm | Soft Tissue Neoplasm | ONTOLOGY_EXACT | 0.98 |
| Soft Tissue Sarcoma | Soft Tissue Sarcoma | ONTOLOGY_EXACT | 0.90 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Registration | Other | — | UNRESOLVED |
Design
Arms and outcomes
Arms (0)
[]Primary outcomes (1)
- measure
- Overall survival rate
- timeFrame
- up to 20 years after first line treatment
Eligibility
Eligibility (as posted)
- Sex
- All
Show eligibility criteria text
Inclusion Criteria: * all primary bone and soft tissue sarcoma defined by th WHO classification 2013 Exclusion Criteria: * all non- primary sarcomas * patient's wish
References
Publications (0)
Data not yet available
No reference posted for this study.